tiprankstipranks
Trending News
More News >
Ardent Health Partners, Inc. (ARDT)
NYSE:ARDT
US Market
Advertisement

Ardent Health Partners, Inc. (ARDT) Stock Forecast & Price Target

Compare
77 Followers
See the Price Targets and Ratings of:

ARDT Analyst Ratings

Moderate Buy
7Ratings
Moderate Buy
6 Buy
0 Hold
1 Sell
Based on 7 analysts giving stock ratings to
Ardent
Health Partners, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ARDT Stock 12 Month Forecast

Average Price Target

$19.92
▲(80.11%Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Ardent Health Partners, Inc. in the last 3 months. The average price target is $19.92 with a high forecast of $24.00 and a low forecast of $14.60. The average price target represents a 80.11% change from the last price of $11.06.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"$11","18":"$18","25":"$25","14.5":"$14.5","21.5":"$21.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$24.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19.92,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$19.92</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.60</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,14.5,18,21.5,25],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.73,14.52,15.31,16.1,16.89,17.68,18.47,19.259999999999998,20.05,20.84,21.63,22.42,23.21,{"y":24,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.73,14.206153846153846,14.682307692307694,15.15846153846154,15.634615384615385,16.110769230769233,16.586923076923078,17.063076923076924,17.53923076923077,18.01538461538462,18.49153846153846,18.96769230769231,19.443846153846156,{"y":19.92,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.73,13.796923076923077,13.863846153846154,13.930769230769231,13.997692307692308,14.064615384615385,14.131538461538462,14.198461538461538,14.265384615384615,14.332307692307692,14.399230769230769,14.466153846153846,14.533076923076923,{"y":14.6,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.97,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.97,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.83,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.91,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.7,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.35,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.08,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.66,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.97,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.59,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.41,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.73,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$24.00Average Price Target$19.92Lowest Price Target$14.60
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ARDT
TipRanks AITipRanks
Not Ranked
TipRanks
$13.5
Buy
22.06%
Upside
Reiterated
07/17/25
Ardent Health Partners' strong financial performance and positive earnings call sentiments are key strengths. However, weak technical indicators and the absence of a dividend yield limit the overall attractiveness of the stock. Despite these challenges, the company's low P/E ratio suggests potential undervaluation.
Guggenheim Analyst forecast on ARDT
Jason CassorlaGuggenheim
Guggenheim
$18
Buy
62.75%
Upside
Reiterated
07/21/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ardent Health Partners, Inc. (NYSE: ARDT), Amgen (NASDAQ: AMGN) and Cross Country Healthcare (NASDAQ: CCRN)
Bank of America Securities Analyst forecast on ARDT
Joanna GajukBank of America Securities
Bank of America Securities
$14.6
Sell
32.01%
Upside
Downgraded
07/16/25
Ardent Health Partners Downgraded to Underperform Amid Legislative Challenges and Financial Strain
RBC Capital Analyst forecast on ARDT
Ben HendrixRBC Capital
RBC Capital
$21
Buy
89.87%
Upside
Reiterated
07/14/25
Ardent Health Partners, Inc. (ARDT) Gets a Buy from RBC Capital
Leerink Partners Analyst forecast on ARDT
Whit MayoLeerink Partners
Leerink Partners
Buy
Reiterated
07/11/25
Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (NYSE: ARDT), AbbVie (NYSE: ABBV) and Accuray (NASDAQ: ARAY)
KeyBanc
$24
Buy
117.00%
Upside
Reiterated
06/20/25
Ardent Health Partners, Inc. (ARDT) Gets a Buy from KeyBanc
Morgan Stanley Analyst forecast on ARDT
Craig HettenbachMorgan Stanley
Morgan Stanley
$22
Buy
98.92%
Upside
Reiterated
06/17/25
Ardent Health Partners, Inc.: Strategic Growth and Stable Outlook Justify Buy Rating
Truist Financial Analyst forecast on ARDT
David S MacdonaldTruist Financial
Truist Financial
Buy
Reiterated
05/07/25
Analysts Offer Insights on Healthcare Companies: Curis (NASDAQ: CRIS), Ardent Health Partners, Inc. (NYSE: ARDT) and Agilon Health (NYSE: AGL)
Mizuho Securities Analyst forecast on ARDT
Ann HynesMizuho Securities
Mizuho Securities
$19$18
Buy
62.75%
Upside
Reiterated
04/09/25
Ardent Health price target lowered to $18 from $19 at MizuhoArdent Health price target lowered to $18 from $19 at Mizuho
J.P. Morgan Analyst forecast on ARDT
Benjamin RossiJ.P. Morgan
J.P. Morgan
$20$18
Hold
62.75%
Upside
Reiterated
03/12/25
Ardent Health Partners, Inc. (ARDT) Receives a Hold from J.P. Morgan
Loop Capital Markets Analyst forecast on ARDT
Timothy GreavesLoop Capital Markets
Loop Capital Markets
$21
Buy
89.87%
Upside
Reiterated
01/08/25
Loop Capital Markets Sticks to Its Buy Rating for Ardent Health Partners, Inc. (ARDT)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ARDT
TipRanks AITipRanks
Not Ranked
TipRanks
$13.5
Buy
22.06%
Upside
Reiterated
07/17/25
Ardent Health Partners' strong financial performance and positive earnings call sentiments are key strengths. However, weak technical indicators and the absence of a dividend yield limit the overall attractiveness of the stock. Despite these challenges, the company's low P/E ratio suggests potential undervaluation.
Guggenheim Analyst forecast on ARDT
Jason CassorlaGuggenheim
Guggenheim
$18
Buy
62.75%
Upside
Reiterated
07/21/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ardent Health Partners, Inc. (NYSE: ARDT), Amgen (NASDAQ: AMGN) and Cross Country Healthcare (NASDAQ: CCRN)
Bank of America Securities Analyst forecast on ARDT
Joanna GajukBank of America Securities
Bank of America Securities
$14.6
Sell
32.01%
Upside
Downgraded
07/16/25
Ardent Health Partners Downgraded to Underperform Amid Legislative Challenges and Financial Strain
RBC Capital Analyst forecast on ARDT
Ben HendrixRBC Capital
RBC Capital
$21
Buy
89.87%
Upside
Reiterated
07/14/25
Ardent Health Partners, Inc. (ARDT) Gets a Buy from RBC Capital
Leerink Partners Analyst forecast on ARDT
Whit MayoLeerink Partners
Leerink Partners
Buy
Reiterated
07/11/25
Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (NYSE: ARDT), AbbVie (NYSE: ABBV) and Accuray (NASDAQ: ARAY)
KeyBanc
$24
Buy
117.00%
Upside
Reiterated
06/20/25
Ardent Health Partners, Inc. (ARDT) Gets a Buy from KeyBanc
Morgan Stanley Analyst forecast on ARDT
Craig HettenbachMorgan Stanley
Morgan Stanley
$22
Buy
98.92%
Upside
Reiterated
06/17/25
Ardent Health Partners, Inc.: Strategic Growth and Stable Outlook Justify Buy Rating
Truist Financial Analyst forecast on ARDT
David S MacdonaldTruist Financial
Truist Financial
Buy
Reiterated
05/07/25
Analysts Offer Insights on Healthcare Companies: Curis (NASDAQ: CRIS), Ardent Health Partners, Inc. (NYSE: ARDT) and Agilon Health (NYSE: AGL)
Mizuho Securities Analyst forecast on ARDT
Ann HynesMizuho Securities
Mizuho Securities
$19$18
Buy
62.75%
Upside
Reiterated
04/09/25
Ardent Health price target lowered to $18 from $19 at MizuhoArdent Health price target lowered to $18 from $19 at Mizuho
J.P. Morgan Analyst forecast on ARDT
Benjamin RossiJ.P. Morgan
J.P. Morgan
$20$18
Hold
62.75%
Upside
Reiterated
03/12/25
Ardent Health Partners, Inc. (ARDT) Receives a Hold from J.P. Morgan
Loop Capital Markets Analyst forecast on ARDT
Timothy GreavesLoop Capital Markets
Loop Capital Markets
$21
Buy
89.87%
Upside
Reiterated
01/08/25
Loop Capital Markets Sticks to Its Buy Rating for Ardent Health Partners, Inc. (ARDT)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ardent Health Partners, Inc.

1 Month
xxx
Success Rate
4/8 ratings generated profit
50%
Average Return
-3.99%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -3.99% per trade.
3 Months
xxx
Success Rate
3/10 ratings generated profit
30%
Average Return
-11.03%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 30.00% of your transactions generating a profit, with an average return of -11.03% per trade.
1 Year
Whit MayoLeerink Partners
Success Rate
0/10 ratings generated profit
0%
Average Return
-27.52%
reiterated a buy rating 16 days ago
Copying Whit Mayo's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -27.52% per trade.
2 Years
xxx
Success Rate
0/10 ratings generated profit
0%
Average Return
-27.52%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -27.52% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ARDT Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
5
4
3
6
6
Buy
8
6
9
10
16
Hold
4
3
3
1
1
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
17
13
15
17
24
In the current month, ARDT has received 22 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. ARDT average Analyst price target in the past 3 months is 19.92.
Each month's total comprises the sum of three months' worth of ratings.

ARDT Financial Forecast

ARDT Earnings Forecast

Next quarter’s earnings estimate for ARDT is $0.30 with a range of $0.19 to $0.58. The previous quarter’s EPS was $0.29. ARDT beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.13% of the time in the same period. In the last calendar year ARDT has Outperformed its overall industry.
Next quarter’s earnings estimate for ARDT is $0.30 with a range of $0.19 to $0.58. The previous quarter’s EPS was $0.29. ARDT beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.13% of the time in the same period. In the last calendar year ARDT has Outperformed its overall industry.

ARDT Sales Forecast

Next quarter’s sales forecast for ARDT is $1.52B with a range of $1.49B to $1.59B. The previous quarter’s sales results were $1.50B. ARDT beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year ARDT has Outperformed its overall industry.
Next quarter’s sales forecast for ARDT is $1.52B with a range of $1.49B to $1.59B. The previous quarter’s sales results were $1.50B. ARDT beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year ARDT has Outperformed its overall industry.

ARDT Stock Forecast FAQ

What is ARDT’s average 12-month price target, according to analysts?
Based on analyst ratings, Ardent Health Partners, Inc.’s 12-month average price target is 19.92.
    What is ARDT’s upside potential, based on the analysts’ average price target?
    Ardent Health Partners, Inc. has 80.11% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ARDT a Buy, Sell or Hold?
          Ardent Health Partners, Inc. has a consensus rating of Moderate Buy which is based on 6 buy ratings, 0 hold ratings and 1 sell ratings.
            What is Ardent Health Partners, Inc.’s price target?
            The average price target for Ardent Health Partners, Inc. is 19.92. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $24.00 ,the lowest forecast is $14.60. The average price target represents 80.11% Increase from the current price of $11.06.
              What do analysts say about Ardent Health Partners, Inc.?
              Ardent Health Partners, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of ARDT?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis